~~<i id='149EE087AE'><strike id='149EE087AE'><tt id='149EE087AE'><pre id='149EE087AE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

focus

author：knowledge 2025-10-02 23:59:25 - browse：33

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Why Eli Lilly’s earnings didn’t quite live up to the hype

knowledge

explore

hotspot

knowledge

Wikipedia

AlexHogan/STATYou’rereadingthewebeditionofD.C.Diagnosis. Signuphere toreceivethisnewsletterinyourinb

WSS

How to protect patients from sexual assault

Eli Lilly reports tirzepatide MASH success during Q4 earnings

AMAs digital advisors table RPM coding reform proposal, again

Listen: Biogen's potential pivot, & Illumina's next chapter

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Humana sues Biden admin over Medicare Advantage audit rule

explore

focus

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Doctors on social media are being harassed and cyberbullied

Affirmative action in medical school literally saved lives

AstraZeneca chief proposes a novel edit to the drug pricing bill

Heart attack and stroke risk calculators need revising

Ethical issues complicate the benefits of medical crowdfunding

Anesthesiologist group: stop taking Ozempic before surgery

The (many) problems with a new study criticizing cancer screening

Anesthesiologist group: stop taking Ozempic before surgery

Here’s what’s in the FDA plan to include pregnant women in clinical trials

explore

'Make People Better': The CRISPR babies story you probably don't know

How to protect patients from sexual assault

Having children helps parents live longer, especially after age 80

Amazon on where the company's health care bets are headed next

Having children helps parents live longer, especially after age 80

Why don't Americans have at

explore

hotspot

knowledge

Wikipedia